Skip to Content
MilliporeSigma

GF21658642

Samarium

foil, not light tested, 25x25mm, thickness 0.025mm, as rolled, 99%

Synonym(s):

Samarium, SM000200

Slide 1 of 2
Sign Into View Organizational & Contract Pricing

Select a Size

Pricing and availability is not currently available.

About This Item

Empirical Formula (Hill Notation):
Sm
CAS Number:
7440-19-9
Molecular Weight:
150.36
MDL number:
MFCD00011233
UNSPSC Code:
12141612
PubChem Substance ID:
329803346
NACRES:
NA.23

Key Documents

View All Documentation

Skip To

Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist

assay

99%

form

foil

manufacturer/tradename

Goodfellow 216-586-42

resistivity

91.4 μΩ-cm, 0°C

size × thickness

25 x 25 mm × 0.025 mm

bp

1794 °C (lit.)

mp

1074 °C (lit.)

density

7.47 g/mL at 25 °C (lit.)

SMILES string

[Sm]

InChI

1S/Sm

InChI key

KZUNJOHGWZRPMI-UHFFFAOYSA-N

Looking for similar products? Visit Product Comparison Guide

Compare Similar Items

View Full Comparison

Show Differences

1 of 4

This Item
GF52166943GF75301668GF47928460
Samarium foil, not light tested, 25x25mm, thickness 0.025mm, as rolled, 99%

GF21658642

Samarium

Samarium foil, not light tested, 25x25mm, thickness 0.005mm, as rolled, 99%

GF52166943

Samarium

Samarium foil, not light tested, 50x50mm, thickness 0.025mm, as rolled, 99%

GF75301668

Samarium

Samarium foil, thickness 0.5 mm, 15 mm diameter, purity 99%

GF47928460

Samarium

manufacturer/tradename

Goodfellow 216-586-42

manufacturer/tradename

Goodfellow 521-669-43

manufacturer/tradename

Goodfellow 753-016-68

manufacturer/tradename

Goodfellow 479-284-60

assay

99%

assay

99%

assay

99%

assay

99%

form

foil

form

foil

form

foil

form

foil

density

7.47 g/mL at 25 °C (lit.)

density

7.47 g/mL at 25 °C (lit.)

density

7.47 g/mL at 25 °C (lit.)

density

7.47 g/mL at 25 °C (lit.)

bp

1794 °C (lit.)

bp

1794 °C (lit.)

bp

1794 °C (lit.)

bp

1794 °C (lit.)

mp

1074 °C (lit.)

mp

1074 °C (lit.)

mp

1074 °C (lit.)

mp

1074 °C (lit.)

General description

For updated SDS information please visit www.goodfellow.com.

Legal Information

Product of Goodfellow

pictograms

Flame
GHS02

signalword

Warning

hcodes

H261

Hazard Classifications

Water-react 3

Storage Class

4.3 - Hazardous materials which set free flammable gases upon contact with water

wgk_germany

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

It looks like we've run into a problem, but you can still download Certificates of Analysis from our Documents section.

If you need assistance, please contact Customer Support

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Samarium(II)-iodide-mediated cyclizations in natural product synthesis.
David J Edmonds et al.
Chemical reviews, 104(7), 3371-3404 (2004-07-15)
Michal Szostak et al.
Chemical communications (Cambridge, England), 48(3), 330-346 (2011-09-01)
Samarium diiodide (SmI(2)) is one of the most important reductive electron transfer reagents available in the laboratory. Key to the popularity of SmI(2) is the ability of additives and co-solvents to tune the properties of the reagent. Over the last
Pete Anderson et al.
Expert review of anticancer therapy, 7(11), 1517-1527 (2007-11-21)
Radiation therapy can be an effective means to treat bone metastases, which occur in more than 50% of cancer patients. (153)Samarium lexidronam ((153)Sm-EDTMP; Quadramet, Cytogen) is a radiopharmaceutical designed for deposition into bone metastases. Bone scans can identify patients that
Y Kamochi et al.
Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan, 120(3), 245-255 (2000-03-21)
This review deals with the rapid reduction of a variety of organic functionalities, including a new selective reduction of carboxylic acid, with samarium diiodide in the presence of additives under mild conditions. The single electron donor ability of samarium diiodide
A N Serafini
Cancer, 88(12 Suppl), 2934-2939 (2000-07-18)
In patients with bone pain due to metastatic disease, intravenous systemic radioisotope therapy may be a useful adjunct to other methods for palliating pain. Various studies have been performed utilizing a short-lived radioisotope conjugated to a tetraphosphonate (samarium 153 lexidronam)
View All Related Papers

Questions

Reviews

No rating value

Active Filters

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service